Midgard Science

Altruist Bio

Hangzhou, China altruistbio.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Altruist Biologics is a CDMO that provides development and GMP manufacturing services for biologics and bioconjugates, including antibodies, fusion proteins, recombinant proteins, and antibody drug conjugates. It serves customers developing and commercializing these products from early development through commercial supply, with facilities in Suzhou and Hangzhou, China.

Services

  • Mammalian Cell Line Development

    Develops high-yield, stable mammalian cell lines and establishes primary, master, and working cell banks under GMP conditions.

    Cell line development

  • Process Development

    Provides cell culture process development, scale-up, process characterization, validation, and toxicology and clinical sample preparation.

  • Formulation Development

    Develops robust formulations for drug substance and drug product, including container closure, in-use stability, and high-concentration formulation work.

  • Analytical Method Development

    Develops, transfers, and validates analytical methods for CMC requirements, release testing, characterization, and stability studies.

  • GMP Drug Substance Manufacturing

    Provides clinical- and commercial-scale GMP drug substance manufacturing for biologics.

    CDMO: development & manufacturing

  • GMP Drug Product Manufacturing

    Provides clinical- and commercial-scale GMP drug product manufacturing.

    CDMO: development & manufacturing

  • Labeling & Packaging

    Offers labeling and packaging services as part of manufacturing support.

  • ADC and Bioconjugation Development

    Develops antibody drug conjugates and other bioconjugates, including payload, linker, and assembly work.

1 more services
  • Regulatory Support
Turnaround
  • 10 weeks from DNA to Primary Cell Bank generation
  • Six or more months to evaluate final formulation

Capabilities

Assays and studies
  • ADCs
  • Antibodies
  • Process development
  • Analytical development
  • Bispecifics
  • CHO
14 more
  • Bioreactors
  • Stability studies
  • Bioassays
  • Binding ELISA
  • Peptide mapping
  • CE-SDS
  • SEC
  • icIEF
  • CEX
  • Residual DNA testing
  • HCP testing
  • Protein A testing
  • Comparability testing
  • Stability testing
Scale and capacity
  • 50 L to 500 L non-GMP pilot scales
  • 1 kL to 20 kL
  • 1,000 L to 20,000 L
  • 4 x 20,000 L stainless steel bioreactors
  • 232,000 liters expected total capacity by 2026
Therapeutic areas
  • Cancer
  • Cardiovascular disease
  • Metabolic disease
  • Autoimmune disease
  • Eye disease

Instruments and platforms

  • Ambr 250
  • ÄKTA pure
  • ÄKTA avant
  • ÄKTA pcc
  • Beckman Biomek i5 workstation
  • ÄKTA process
3 more
  • ÄKTA ready
  • Tecan
  • LabChip

Modalities and species

Modalities
  • Antibody
  • Bispecific
  • ADC
  • Recombinant protein
Species and models
  • Mammalian cell culture
  • CHO-K1
  • CHO-S
  • CHO-K1 GS-KO

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: drug substance manufacturing, drug product manufacturing, clinical and commercial production

Company

Type
CDMO
Founded
2022
Team
1.2K+ Highly Skilled Employees

Locations

Based in
Hangzhou, China
Sites
Suzhou, China
Serves
Global

Similar labs